X-Nav Technologies Reports X-Guide Dynamic Navigation Receives FDA 510(k) Clearance To Aid in Minimally Invasive Endodontic Procedures

X-Nav Technologies, LLC, a leading creator of image-guided and robot-assisted surgical products, announced that it has received clearance from the U.S. Food and Drug Administration to expand the use of its X-Guide® Dynamic Surgical Navigation system to aid dentists in delivering minimally invasive endodontic procedures.

According to X-Nav Technologies, with the X-Guide dynamic navigation, patients and dentists can now benefit from more precise and minimally invasive access to tooth structures needing endodontic treatment – specifically, access to calcified canals and apicoectomies of affected teeth.

“X-Guide dynamic navigation is an extremely accurate solution to a common endodontic challenge: calcified root canal systems,” according to L. Stephen Buchanan, DDS, FICD, FACD of Santa Barbara, CA. “With X-Guide, I can perform minimally invasive root canal therapy (RCT) with much more predictability and less stress.”

Using the X-Guide system’s patented X-Point™ technology, the dentist gains a live view of the patient’s 3D anatomy and a digital handpiece to guide drill movements during surgery. This allows the dentist to precisely navigate their drill to an exact access location for more efficient endodontic procedures. Tools in the X-Guide software help make navigation easy to integrate into the endodontic workflow, like the virtual Prep feature for planning and following an ideal drill path, X-Mark™ virtual registration for using small, medium and large field of view CBCTs, and integration with high-speed handpieces.

Combining 3D imaging with X-Guide navigation allows dentists to locate and access endodontic tooth structures more precisely, which is useful to:

  • achieve less invasive access and prep of calcified and hidden canals
  • perform minimally invasive apicoectomy and root-end access
  • minimize damage to anatomical structures
  • preserve tooth structure
  • save time and potentially reduce intra-operative imaging

“In teeth with calcification, X-Guide dynamic guidance can be used to reduce structural weakening through minimally-invasive endodontic procedures,” stated Dr. Charles Maupin, DDS of Lubbock, TX.

According to studies, “The dynamic navigation system was more accurate and more efficient in root-end resection in a cadaver model than the freehand technique. The dynamic navigation system has the potential to be a safe and reliable technological addition to endodontic microsurgery.”1

Dr. Frederico Martinho, DDS, M.Sc., PhD, and Clinical Associate Professor at the University of Maryland School of Dentistry, shared that “Our recent studies with X-Guide focused on minimally invasive access cavity, post removal, locating calcified canals, and endodontic microsurgery. It has the potential to improve accuracy, reduce surgical time, and operator mishaps. Both the endodontic residents and I were able to quickly master the technology – the learning curve was not steep for novel or experienced endodontists.”

X-Nav Technologies notes the X-Guide system has gained global recognition for giving dental surgeons the ability to perform more accurate and precise dental implant procedures, compared to freehand surgery. Over 175,000 dental implants have been surgically placed using the X-Guide system around the world.

“As X-Guide surgical navigation became an integral part of dental implant surgery, it also became clear that expanding access to our technology for endodontic procedures would improve provider capabilities and patient experiences. I’m proud of our talented team of clinical and engineering masterminds for being able to deliver the benefits of surgical navigation to more dental professionals,” said Edward Marandola, President, CEO, and Co-Founder of X-Nav Technologies.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version